Trexquant Investment LP Meira G Tx Holdings PLC Transaction History

Trexquant Investment LP

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$5.78 - $7.33 $92,416 - $117,199	15,989 New	15,989 $97,000
Q2 2023 Aug 11, 2023	SELL	$5.19 - $8.07 $40,123 - $62,389	-7,731 Reduced 21.84%	27,662 $185,000
Q1 2023 May 15, 2023	SELL	$5.04 - $8.6 $140,404 - $239,578	-27,858 Reduced 44.04%	35,393 $182,000
Q4 2022 Feb 13, 2023	BUY	$5.8 - $8.98 $215,412 - $333,517	37,140 Added 142.24%	63,251 $412,000
Q3 2022 Nov 14, 2022	SELL	$7.55 - $11.25 $45,941 - $68,456	-6,085 Reduced 18.9%	26,111 $220,000
Q2 2022 Aug 11, 2022	BUY	$6.8 - $14.23 $39,236 - $82,107	5,770 Added 21.83%	32,196 $244,000
Q1 2022 May 13, 2022	BUY	$13.42 - $23.38 $354,636 - $617,839	26,426 New	26,426 $366,000
Q4 2021 Feb 14, 2022	SELL	$12.78 - $23.74 $158,778 - $294,945	-12,424 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$11.73 - $16.08 $145,733 - $199,777	12,424 New	12,424 $164,000
Q1 2021 May 13, 2021	SELL	$13.84 - $17.8 $226,588 - $291,421	-16,372 Closed	0 $0
Q4 2020 Feb 11, 2021	BUY	$12.4 - $17.6 $203,012 - $288,147	16,372 New	16,372 $248,000
Q4 2019 Feb 12, 2020	SELL	$13.91 - $21.48 $186,950 - $288,691	-13,440 Closed	0 $0
Q3 2019 Nov 08, 2019	BUY	$15.84 - $30.01 $212,889 - $403,334	13,440 New	13,440 $214,000

100

45.4M

19.2K

31K

Ticker MGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,010,700
Market Cap $292M
Description
MeiraGTx Holdings plc, a clinical stage gene therapy company, focusing on developing treatments for patients with serious diseases. The company develops various therapies for ocular diseases, including inherited blindness, as well as Xerostomia following radiation treatment for head and neck cancers; degenerative diseases; neurodegenerative dise...

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

Stay updated on Trexquant Investment LP with notifications on news.